Israeli Pharma Co. Wants NY Stock-Drop Class Suit Tossed
An Israel-based pharmaceutical company urged a New York federal judge Wednesday to toss a proposed class action alleging it falsified late-stage trial results for a hypertension treatment and subsequently caused the...To view the full article, register now.
Already a subscriber? Click here to view full article